Blocking chemical allows immune cells to reduce Alzheimer's plaques

Published on Monday 09 June 2008 - 11:09

Summary :
A team of researchers from Yale University has discovered that inactivating a chemical enables immune cells to remove the plaques that cause Alzheimer's disease.
Read more

Information source

dailyindia.com News Feed

http://www.dailyindia.com

Website description
DailyIndia.com is your source for the latest news headlines on India.

Articles published on this website : 0 / 7 days - 2 / 30 days

2 proteins in cardiovascular system pose a double MRI brain scans may offer accurate, early Alzhimer's Studying how nitric oxide alters brain function can Chemicals that can halt Alzheimer's, Parkinson's by preventing Educated people less prone to Alzheimer's

Other articles published on other websites on the same day

Alzheimer's Drug Discovery Foundation Invites Scientists to Apply for Grant Award Program http://www.marketwire.com/ Risks of Long-term Mobile Phone Use Studied http://www.medindia.com/ Richard Ramlall, RCN Senior VP, Strategic External Affairs & Programming, Appointed to Alzheimer's Association --National Capital Area Board of... http://www.redorbit.com/ 115-Year-Old Woman Had Normal Brain http://www.redorbit.com/ Emergence of Drugs From Elan/Wyeth, Eli Lilly, Myriad Genetics and Medivation Will Drive the Alzheimer's Disease Drug Market to Nearly Triple By 2017 http://www.redorbit.com/ Avid Radiopharmaceuticals Initiates First Phase II Trial of Novel Compound for Imaging Alzheimer's Disease http://www.pharmiweb.com/ QBI neuroscientists make Alzheimer's disease advance http://www.uq.edu.au/ Emergence of Drugs from Elan/Wyeth, Eli Lilly, Myriad Genetics and Medivation Will Drive the Alzheimer's Disea http://www.pharmiweb.com/ Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's... http://www.prnewswire.com/ Emergence of Drugs from Elan/Wyeth, Eli Lilly, Myriad Genetics and Medivation Will Drive the Alzheimer's Disease Drug Market to Nearly Triple by 2017 http://www.prnewswire.com/